Tibotec
If you are not a Medical Doctor and/or are looking for general information, please send an e mail to info@tibbe.jnj.com and Tibotec will contact you. ...
http://www.tibotec.com/bgdisplay.jhtml?itemname=investigator...
|
Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying ...
... please see http://www.clinicaltrials.gov or email info@tibbe.jnj.com. About Tibotec Pharmaceuticals Ltd. Tibotec Pharmaceuticals Ltd., based in Cork, ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...
|
Design and cloning strategies for constructing shRNA expression ...
Glen J McIntyre: gmcinty1/at/medau.jnj.com; Gregory C Fanning: gfannin1/at/tibbe .jnj.com. Received September 20, 2005; Accepted January 5, 2006. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=13...
|
BMC Biotechnology
Email: Glen J McIntyre - gmcinty1@medau.jnj.com; Gregory C Fanning* - gfannin1@ tibbe.jnj.com. * Corresponding author. Abstract ...
http://www.biomedcentral.com/content/pdf/1472-6750-6-1.pdf...
|
Prevention of Drug Carryover Effects in Studies Assessing ...
Mailing address: BVBA, Johnson & Johnson, Turnhoutseweg 30, Beerse 2340, Belgium . Phone: 32 14 60 65 71. Fax: 32 14 60 54 03. E-mail: nlounis/at/tibbe.jnj. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=24...
|
1472-6750-6-1 1472-6750 Methodology article Design and cloning ...
... expression vectors McIntyre J Glen gmcinty1@medau.jnj.com Fanning C Gregory gfannin1@tibbe.jnj.com Johnson and Johnson Research Pty Ltd, 1 Central Ave, ...
http://www.biomedcentral.com/content/download/xml/1472-6750-...
|
BioPortfolio - Tibotec, Inc
1020 Stony Hill Road Suite 300. Yardley. Pennsylvania. 19067. United States of America. Tel: 1 609 730 7500. Fax: 1 609 730 7501. Email: info@tibbe.jnj.com ...
http://www.bioportfolio.com/biocorporate/31076-Tibotec,_Inc....
|
Accelerating Discoveries, Offering Innovations
Email: info@tibbe.jnj.com. www.tibotec.com. Tibotec Therapeutics. 440 Rt. 22 East. Bridgewater, NJ 08807-0914. USA. Tel: +1 908-541-4747 ...
http://www.tibotec.com/content/backgrounders/www.tibotec.com...
|
Tibotec Pharmaceuticals Ltd Conducts Two Pivotal Phase III ...
For additional information on inclusion and exclusion criteria for both of these studies, please see www.clinicaltrials.gov or email info@tibbe.jnj.com. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=103607...
|
Pharmacokinetic interaction between TMC114/ritonavir and tenofovir ...
Tel: +32 1529 3100 Fax: +32 1528 6347 E-mail:rhoetelm/at/tibbe.jnj.com. Received January 23, 2007; Accepted March 26, 2007. Top. > Abstract. Introduction ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=22...
|
